ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.713,71
0,17%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,08369
0,11%
Bitcoin
69.694,56
0,86%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. TriSalus Life Sciences Inc (TLSI)

  7. TriSalus Life Sciences Inc (TLSI) News

TLSI

TriSalus Life Sciences (TLSI)

TriSalus Life Sciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TLSI
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202414h00Business WireTriSalus Reports Q1 2024 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
07/05/202413h00Business WireTriSalus Life Sciences Appoints Liselotte Hyveled to its Board of DirectorsNASDAQ:TLSITriSalus Life Sciences Inc
06/05/202422h58Business WireTriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
30/04/202422h35Business WireTriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth InitiativesNASDAQ:TLSITriSalus Life Sciences Inc
01/04/202414h00Business WireTriSalus Reports Q4 and Full Year 2023 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
26/03/202413h00Business WireTriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
21/03/202413h00Business WireTriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
11/03/202422h15Business WireTriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial ResultsNASDAQ:TLSITriSalus Life Sciences Inc
07/03/202413h00Business WireTriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101NASDAQ:TLSITriSalus Life Sciences Inc
29/02/202413h00Business WireTriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver TumorsNASDAQ:TLSITriSalus Life Sciences Inc
15/02/202400h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
15/02/202400h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
15/02/202400h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
15/02/202400h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
15/02/202400h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
25/01/202423h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
25/01/202423h23Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
25/01/202423h21Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
25/01/202423h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
05/01/202422h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
27/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
27/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
26/12/202323h28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
26/12/202323h27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
14/11/202314h00Business WireTriSalus Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
07/11/202322h05Business WireTriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
04/11/202319h25Business WireLate-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas IndicationsNASDAQ:TLSITriSalus Life Sciences Inc
03/11/202317h00Business WireTriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
25/10/202315h05Business WireTriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
19/10/202303h58Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TLSITriSalus Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:TLSI

Kürzlich von Ihnen besucht

LSE
QL38
Morg.st.b.v 25
NASDAQ
AAXIRXX
Bank of Montreal Capped ...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten